Latest Breaking News On - Simon goldsborough - Page 6 : comparemela.com

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies

Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed.

FDA approves Xolair as first and only medicine for children

Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young.

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies

F. Hoffmann-La Roche Ltd: FDA approves Xolair as first and only medicine for children and adults with one or more food allergies

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies

Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young as 1 year treated with Xolair could tolerate.